Drug Profile
Phentermine - Citius Pharmaceuticals
Alternative Names: Phentermine hydrochloride; SuprenzaLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Alpex Pharma
- Developer Citius Pharmaceuticals Inc
- Class Amphetamines; Anorectics; Small molecules
- Mechanism of Action Adrenergic receptor agonists; Central nervous system stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Market Withdrawal Obesity
Most Recent Events
- 01 Jul 2016 Withdrawn for Obesity (Adjunctive treatment) in USA (PO)
- 18 Sep 2014 Citius Pharmaceuticals plans additional phase II trial for Obesity in USA (PO) (Citius Pharmaceuticals, Form 8-K filed in September 2014)
- 01 Apr 2012 Launched for Obesity (Adjunctive treatment, With exercise, behavioural modification and caloric restriction) in USA (PO, 15mg, 30mg)